KMO, kynurenine 3-monooxygenase, 8564

N. diseases: 44; N. variants: 2
Disease: HIV Infections ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019693
Disease: HIV Infections
HIV Infections 		0.020 Biomarker group BEFREE Our data indicate that KMO inhibition in early acute SIV infection provides clinical benefit and suggest a rationale for testing KMO inhibition as an adjunctive treatment in SIV/HIV infection to slow the progression of the disease and improve immune reconstitution. 31285277 2019
CUI: C0019693
Disease: HIV Infections
HIV Infections 		0.020 GeneticVariation group BEFREE The relationships between polymorphisms in KMO and KATII, psychopathological symptoms, and cerebrospinal fluid (CSF) [KYNA] were evaluated in subjects with and without HIV-infection. 27072370 2016